E0 ConsensusPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies.
Zadeh, Farigol Hakem, Wilson, Daniel R, Agrawal, Devendra K · Archives of microbiology & immunology · 2023
Quick Summary
Long COVID refers to symptoms that persist for weeks or months after an initial COVID-19 infection has cleared. This review examines how COVID-19 damages various organs in the body, what causes these problems, and what treatments might help. The authors also discuss how vaccination may affect Long COVID and identify important gaps in our understanding of the condition.
Why It Matters
This comprehensive review is relevant to ME/CFS patients and researchers because Long COVID and ME/CFS share overlapping symptom profiles and proposed mechanisms (such as viral persistence, immune dysfunction, and post-viral fatigue). Understanding Long COVID's pathophysiology and treatment landscape may inform approaches to ME/CFS management and highlight shared research priorities.
Observed Findings
- Long COVID affects multiple organ systems with diverse proposed mechanisms of damage
- Current treatment options remain limited and primarily address symptoms rather than underlying causes
- Vaccination status appears to have some effect on Long COVID development or severity, though details require clarification
- Significant gaps exist in understanding Long COVID's impact on quality of life and long-term health outcomes
- No formal consensus definition for Long COVID has been universally adopted (CDC and WHO definitions differ)
Inferred Conclusions
- Multiple pathophysiological mechanisms likely contribute to Long COVID across different organ systems, suggesting a heterogeneous condition
- Current therapeutic approaches are insufficient and additional research into mechanistic targets is needed
- Long-term follow-up studies are essential to assess quality of life, life expectancy, and potential transgenerational effects
- Future prevention and treatment strategies must identify more specific prognostic and therapeutic targets
Remaining Questions
- What are the primary mechanisms determining why some COVID-19 patients develop persistent symptoms while others recover completely?
What This Study Does Not Prove
This systematic review does not establish causality for specific mechanisms in individual patients, nor does it prove that any single treatment is definitively effective. The review synthesizes existing research but cannot resolve the fundamental question of why some COVID-19 patients develop Long COVID while others do not, and it does not compare outcomes between Long COVID and ME/CFS directly.
Tags
Symptom:Cognitive DysfunctionFatigue
Biomarker:CytokinesBlood Biomarker
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:Exploratory OnlyMixed Cohort
Metadata
- PMID
- 37388279
- Review status
- Machine draft
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →